Dasatinib in children and adolescents with relapsed or refractory leukemia: results of the CA180-018 phase I dose-escalation study of the Innovative Therapies for Children with Cancer Consortium

C Michel Zwaan, Carmelo Rizzari, Francoise Mechinaud, Donna L Lancaster, Thomas Lehrnbecher, Vincent H J van der Velden, B Berna Beverloo, Monique L den Boer, Rob Pieters, Dirk Reinhardt, Michael Dworzak, Julie Rosenberg, George Manos, Shruti Agrawal, Lewis Strauss, André Baruchel, Pamela R Kearns